Financials
Income statement
Fiscal date | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
---|---|---|---|---|
Total reported revenue | 12.5B | 11.3B | 9.3B | 10.0B |
Cost of revenue | 4.4B | 4.2B | 6.1B | 3.4B |
Gross profit | 8.1B | 7.1B | 3.2B | 6.6B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 1.6B | 1.7B | 2.5B | 1.3B |
Other operating expenses | 2.1B | 1.9B | -1.3B | 2.1B |
Operating income | 3.6B | 2.8B | 1.4B | 2.4B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 66.2M | 19.1M | -800K | 224.2M |
Other income expense | — | — | — | — |
Pretax income | 3.6B | 2.9B | 1.1B | 2.3B |
Tax provision | 955.4M | 734.7M | 312.2M | 795.7M |
Net income | 2.7B | 2.1B | 810.6M | 1.5B |
Basic EPS | 82.7 | 65.3 | — | 47.6 |
Diluted EPS | 82.7 | 65.3 | — | 47.6 |
Basic average shares | 32.5M | 32.5M | — | 32.5M |
Diluted average shares | 32.5M | 32.5M | — | 32.5M |
EBITDA | 3.8B | 3.0B | 1.3B | 2.7B |
Net income from continuing op. | — | — | — | — |
Minority interests | — | — | — | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |